ATE140227T1 - 2-saccharinylmethyl-aryl-carboxylate-derivate als proteolytic enzym-inhibitore und zusammensetzungen davon und behandlungsmethoden darauf - Google Patents
2-saccharinylmethyl-aryl-carboxylate-derivate als proteolytic enzym-inhibitore und zusammensetzungen davon und behandlungsmethoden daraufInfo
- Publication number
- ATE140227T1 ATE140227T1 AT93202925T AT93202925T ATE140227T1 AT E140227 T1 ATE140227 T1 AT E140227T1 AT 93202925 T AT93202925 T AT 93202925T AT 93202925 T AT93202925 T AT 93202925T AT E140227 T1 ATE140227 T1 AT E140227T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- treatment
- saccharinylmethyl
- inhibiters
- aryl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000035195 Peptidases Human genes 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- -1 aryl carboxylates Chemical class 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/965,593 US5306818A (en) | 1990-11-01 | 1992-10-23 | Tetrahydro 2-saccharinylmerthyl aryl carboxylates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE140227T1 true ATE140227T1 (de) | 1996-07-15 |
Family
ID=25510194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93202925T ATE140227T1 (de) | 1992-10-23 | 1993-10-20 | 2-saccharinylmethyl-aryl-carboxylate-derivate als proteolytic enzym-inhibitore und zusammensetzungen davon und behandlungsmethoden darauf |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5306818A (de) |
| EP (1) | EP0594257B1 (de) |
| JP (1) | JPH06211849A (de) |
| KR (1) | KR940009183A (de) |
| AT (1) | ATE140227T1 (de) |
| AU (1) | AU679446B2 (de) |
| CA (1) | CA2105731A1 (de) |
| CZ (1) | CZ221093A3 (de) |
| DE (1) | DE69303573T2 (de) |
| DK (1) | DK0594257T3 (de) |
| ES (1) | ES2092751T3 (de) |
| FI (1) | FI934675A (de) |
| GR (1) | GR3021300T3 (de) |
| HU (1) | HUT68879A (de) |
| IL (2) | IL107315A (de) |
| MX (1) | MX9305196A (de) |
| MY (1) | MY131384A (de) |
| NO (1) | NO304375B1 (de) |
| NZ (1) | NZ248360A (de) |
| SG (1) | SG50627A1 (de) |
| SK (1) | SK116693A3 (de) |
| TW (1) | TW272973B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5550139A (en) * | 1994-01-03 | 1996-08-27 | The Wichita State University | Serine protease inhibitors |
| DE4427995A1 (de) * | 1994-08-08 | 1996-02-15 | Basf Ag | Saccharinderivate |
| DE4427997A1 (de) * | 1994-08-08 | 1996-02-15 | Basf Ag | 5-Hydroxypyrazol-4-yl-carbonyl-substituierte Saccharinderivate |
| DE4427998A1 (de) * | 1994-08-08 | 1996-02-15 | Basf Ag | Saccharinderivate |
| US5556909A (en) * | 1994-12-02 | 1996-09-17 | Sanofi Winthrop Inc. | Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof |
| PL335740A1 (en) * | 1997-03-10 | 2000-05-08 | Basf Ag | Derivatives of saccharin-5-carbonylcyclohexane-1,3,5-trione |
| US6420401B1 (en) | 1997-08-22 | 2002-07-16 | Wichita State University | 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives |
| EP1212034A1 (de) * | 1999-09-10 | 2002-06-12 | The Procter & Gamble Company | Enzyminhibitoren |
| MY147790A (en) * | 2005-04-28 | 2013-01-31 | Takeda Pharmaceutical | Stable emulsion composition |
| US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
| CA3057261A1 (en) | 2017-04-06 | 2018-10-11 | Inventiva | New compounds inhibitors of the yap/taz-tead interaction and their use in the treatment of malignant mesothelioma |
| EP3632908A1 (de) | 2018-10-02 | 2020-04-08 | Inventiva | Inhibitoren der yap / taz-tead-interaktion und ihre verwendung bei der behandlung von krebs |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3002884A (en) * | 1959-04-15 | 1961-10-03 | Rohm & Haas | Horticultural process with n-halomethyl-1,2-benzisothiazolin - 3 - one-1,1-dioxides for controlling fungus diseases |
| US3314960A (en) * | 1964-08-25 | 1967-04-18 | American Home Prod | Benzisothiazol glutarimides |
| FR1451417A (fr) * | 1965-07-15 | 1966-01-07 | Roussel Uclaf | Nouveaux esters d'acides cycliques et leur procédé de préparation |
| JPS4835457A (de) * | 1971-09-02 | 1973-05-24 | ||
| US4195023A (en) * | 1975-08-20 | 1980-03-25 | Merck & Co., Inc. | 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin |
| US4276298A (en) * | 1978-03-24 | 1981-06-30 | Merck & Co., Inc. | 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors |
| US4263393A (en) * | 1979-09-06 | 1981-04-21 | Eastman Kodak Company | Novel electron donor precursors and photographic element containing them |
| EP0026791B1 (de) * | 1979-10-08 | 1984-05-02 | Merck & Co. Inc. | 2-Aryl-1,2-benzisothiazolinon-1,1-dioxide und sie enthaltende pharmazeutische Zusammensetzungen |
| US4350752A (en) * | 1980-12-29 | 1982-09-21 | Eastman Kodak Company | Photographic elements and film units containing imidomethyl blocked photographic reagents |
| US4363865A (en) * | 1981-03-04 | 1982-12-14 | Eastman Kodak Company | Imido methyl blocked photographic dyes and dye releasing compounds |
| US4410618A (en) * | 1982-06-11 | 1983-10-18 | Eastman Kodak Company | Blocked photographic reagents |
| US4623645A (en) * | 1983-04-18 | 1986-11-18 | Merck & Co., Inc. | Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents |
| US4547371A (en) * | 1983-04-18 | 1985-10-15 | Merck & Co., Inc. | Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents |
| US4659855A (en) * | 1983-05-09 | 1987-04-21 | Georgia Tech Research Corporation | Aryl sulfonyl fluoride compounds |
| DE3617976A1 (de) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten |
| WO1990013549A1 (en) * | 1989-05-04 | 1990-11-15 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof |
| US5236917A (en) * | 1989-05-04 | 1993-08-17 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| FR2659327A1 (fr) * | 1990-03-08 | 1991-09-13 | Centre Nat Rech Scient | Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases. |
| AU642537B2 (en) * | 1990-11-01 | 1993-10-21 | Sanofi | 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| AU656027B2 (en) * | 1991-11-15 | 1995-01-19 | Sanofi | Saccharin derivative proteolytic enzime inhibitors |
| AU653279B2 (en) * | 1991-12-30 | 1994-09-22 | Sanofi | Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| TW226016B (de) * | 1991-12-30 | 1994-07-01 | Sterling Winthrop Inc |
-
1992
- 1992-10-23 US US07/965,593 patent/US5306818A/en not_active Expired - Fee Related
-
1993
- 1993-08-09 NZ NZ248360A patent/NZ248360A/en unknown
- 1993-08-10 AU AU44526/93A patent/AU679446B2/en not_active Ceased
- 1993-08-20 KR KR1019930016236A patent/KR940009183A/ko not_active Application Discontinuation
- 1993-09-08 CA CA002105731A patent/CA2105731A1/en not_active Abandoned
- 1993-09-17 JP JP5231485A patent/JPH06211849A/ja not_active Withdrawn
- 1993-09-22 TW TW082107789A patent/TW272973B/zh active
- 1993-09-26 MX MX9305196A patent/MX9305196A/es not_active IP Right Cessation
- 1993-10-18 IL IL10731593A patent/IL107315A/en not_active IP Right Cessation
- 1993-10-18 IL IL107315A patent/IL107315A0/xx unknown
- 1993-10-19 CZ CZ932210A patent/CZ221093A3/cs unknown
- 1993-10-20 ES ES93202925T patent/ES2092751T3/es not_active Expired - Lifetime
- 1993-10-20 DE DE69303573T patent/DE69303573T2/de not_active Expired - Fee Related
- 1993-10-20 EP EP93202925A patent/EP0594257B1/de not_active Expired - Lifetime
- 1993-10-20 AT AT93202925T patent/ATE140227T1/de not_active IP Right Cessation
- 1993-10-20 DK DK93202925.9T patent/DK0594257T3/da active
- 1993-10-20 SG SG1996007173A patent/SG50627A1/en unknown
- 1993-10-22 SK SK1166-93A patent/SK116693A3/sk unknown
- 1993-10-22 FI FI934675A patent/FI934675A/fi unknown
- 1993-10-22 HU HU9303009A patent/HUT68879A/hu unknown
- 1993-10-22 MY MYPI93002196A patent/MY131384A/en unknown
- 1993-10-22 NO NO933817A patent/NO304375B1/no unknown
-
1996
- 1996-10-09 GR GR960402671T patent/GR3021300T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK116693A3 (en) | 1995-02-08 |
| NO933817D0 (no) | 1993-10-22 |
| EP0594257A1 (de) | 1994-04-27 |
| AU679446B2 (en) | 1997-07-03 |
| SG50627A1 (en) | 1998-07-20 |
| JPH06211849A (ja) | 1994-08-02 |
| TW272973B (de) | 1996-03-21 |
| CA2105731A1 (en) | 1994-04-24 |
| NO304375B1 (no) | 1998-12-07 |
| HUT68879A (en) | 1995-08-28 |
| KR940009183A (ko) | 1994-05-20 |
| FI934675A (fi) | 1994-04-24 |
| IL107315A (en) | 1999-03-12 |
| CZ221093A3 (en) | 1994-05-18 |
| DK0594257T3 (da) | 1996-11-11 |
| EP0594257B1 (de) | 1996-07-10 |
| IL107315A0 (en) | 1994-01-25 |
| US5306818A (en) | 1994-04-26 |
| HU9303009D0 (en) | 1994-01-28 |
| MY131384A (en) | 2007-08-30 |
| NO933817L (no) | 1994-04-25 |
| AU4452693A (en) | 1994-05-05 |
| DE69303573T2 (de) | 1997-02-27 |
| MX9305196A (es) | 1994-05-31 |
| NZ248360A (en) | 1995-08-28 |
| GR3021300T3 (en) | 1997-01-31 |
| ES2092751T3 (es) | 1996-12-01 |
| FI934675A0 (fi) | 1993-10-22 |
| DE69303573D1 (de) | 1996-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO941662D0 (no) | Benzofuranyl- og -tiofenyl-alkankarboksylsyrederivater | |
| FI906438A (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi | |
| DE69123124D1 (de) | Dihydro-Isoquinolinderivate | |
| FI874570A (fi) | Antibakteriska medel -ii. | |
| NO924915L (no) | Sakkarinderivater med inhiberende virkning paa protolytiske enzymer | |
| ATE140227T1 (de) | 2-saccharinylmethyl-aryl-carboxylate-derivate als proteolytic enzym-inhibitore und zusammensetzungen davon und behandlungsmethoden darauf | |
| FI92198C (fi) | Menetelmä valmistaa farmakologisesti arvokkaita 2-(RS)-substituoituja 2,3-dihydro-5-oksi-4,6,7-trimetyylibentsofuraaneja | |
| DE3782347D1 (de) | Hetaryl-oxy-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel. | |
| DE3777590D1 (de) | 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene-pgi2-derivate. | |
| ATE171704T1 (de) | Optisch wirksame alkylendioxybenzolderivate und ihre verwendung als arzneimittel | |
| ATE146481T1 (de) | Epoxysuccinamidsäurederivat | |
| NO842345L (no) | Heksahydropyrrolo(2,1-a)isoquinolin-derivater. | |
| ATE167869T1 (de) | Thiolderivate von gallensäure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |